| Product Code: ETC8871251 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Poland Precision Oncology Market Overview |
3.1 Poland Country Macro Economic Indicators |
3.2 Poland Precision Oncology Market Revenues & Volume, 2021 & 2031F |
3.3 Poland Precision Oncology Market - Industry Life Cycle |
3.4 Poland Precision Oncology Market - Porter's Five Forces |
3.5 Poland Precision Oncology Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Poland Precision Oncology Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F |
3.7 Poland Precision Oncology Market Revenues & Volume Share, By End-use, 2021 & 2031F |
4 Poland Precision Oncology Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer in Poland |
4.2.2 Technological advancements in precision oncology |
4.2.3 Rising adoption of personalized medicine in oncology treatment |
4.3 Market Restraints |
4.3.1 High cost associated with precision oncology treatments |
4.3.2 Limited reimbursement policies for precision oncology in Poland |
5 Poland Precision Oncology Market Trends |
6 Poland Precision Oncology Market, By Types |
6.1 Poland Precision Oncology Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Poland Precision Oncology Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 Poland Precision Oncology Market Revenues & Volume, By Diagnostics, 2021- 2031F |
6.1.4 Poland Precision Oncology Market Revenues & Volume, By Therapeutics, 2021- 2031F |
6.2 Poland Precision Oncology Market, By Cancer Type |
6.2.1 Overview and Analysis |
6.2.2 Poland Precision Oncology Market Revenues & Volume, By Breast Cancer, 2021- 2031F |
6.2.3 Poland Precision Oncology Market Revenues & Volume, By Colorectal Cancer, 2021- 2031F |
6.2.4 Poland Precision Oncology Market Revenues & Volume, By Cervical Cancer, 2021- 2031F |
6.2.5 Poland Precision Oncology Market Revenues & Volume, By Prostate Cancer, 2021- 2031F |
6.2.6 Poland Precision Oncology Market Revenues & Volume, By Lung Cancer, 2021- 2031F |
6.2.7 Poland Precision Oncology Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Poland Precision Oncology Market, By End-use |
6.3.1 Overview and Analysis |
6.3.2 Poland Precision Oncology Market Revenues & Volume, By Hospitals & Diagnostic Laboratories, 2021- 2031F |
6.3.3 Poland Precision Oncology Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F |
6.3.4 Poland Precision Oncology Market Revenues & Volume, By Healthcare Data Companies, 2021- 2031F |
7 Poland Precision Oncology Market Import-Export Trade Statistics |
7.1 Poland Precision Oncology Market Export to Major Countries |
7.2 Poland Precision Oncology Market Imports from Major Countries |
8 Poland Precision Oncology Market Key Performance Indicators |
8.1 Percentage of cancer patients undergoing precision oncology treatment |
8.2 Number of precision oncology centers in Poland |
8.3 Research and development investment in precision oncology technologies |
9 Poland Precision Oncology Market - Opportunity Assessment |
9.1 Poland Precision Oncology Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Poland Precision Oncology Market Opportunity Assessment, By Cancer Type, 2021 & 2031F |
9.3 Poland Precision Oncology Market Opportunity Assessment, By End-use, 2021 & 2031F |
10 Poland Precision Oncology Market - Competitive Landscape |
10.1 Poland Precision Oncology Market Revenue Share, By Companies, 2024 |
10.2 Poland Precision Oncology Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here